Skip to main content

Table 1 Baseline characteristic of septic patients grouped by the status of premorbid beta-blocker usage

From: Premorbid β1-selective (but not non-selective) β-blocker exposure reduces intensive care unit mortality among septic patients

Variables

Nonusers

n= 1053

Nonselective BB

n= 72

β1-selective BB

n= 137

P value

Age, y/o

68.89±17.30§

66.71±16.73§

73.70±12.88†‡

0.003

Male (n, %)

700(66.5%)

45(62.5%)

94(68.6%)

0.673

APACHEII Score

26.53±8.46

26.86±7.72

26.45±7.33

0.939

Underlying disease (n, %)

 Hypertension

474(45.0%)‡§

43(59.7%)†§

101(73.7%)†‡

<0.001

 DM

345(32.8%)‡§

35(48.6%)†

63(46.0%)†

<0.001

 ESRD

86(8.2%)‡§

17(23.6%)†

19(13.9%)†

<0.001

 Cirrhosis

85(8.1%)‡

12(16.7%)†§

7(5.1%)‡

0.014

 Heart failure

98(9.3%)‡§

13(18.1%)†

26(19.0%)†

<0.001

 Arrhythmia

100(9.5%)§

11(15.3%)

21(15.3%)†

0.043

 CAD

112(10.6%)§

13(18.1%)§

53(38.7%)†‡

<0.001

 COPD

74(7.0%)

4(5.6%)

9(6.6%)

0.881

 Cancer, solid tumor

308(29.2%)

16(22.2%)

35(25.5%)

0.321

 Cancer, hematologic

89(8.5%)§

3(4.2%)

4(2.9%)†

0.038

 Autoimmune disease

58(5.5%)

8(11.1%)

10(7.3%)

0.124

Infectious source (n, %)

 Pneumonia

628(59.6%)

46(63.9%)

91(66.4%)

0.262

 UTI

141(13.4%)

11(15.3%)

23(16.8%)

0.522

 Blood stream infection

163(15.5%)

11(15.3%)

15(10.9%)

0.375

 IAI

285(27.1%)

18(25.0%)

28(20.4%)

0.245

 Soft tissue infection

88(8.4%)

6(8.3%)

10(7.3%)

0.914

Vital signs & lab data

 HR, beats/min

116.40±23.16§

114.89±25.91

109.52±22.74†

0.005

 Mean BP, mmHg

61.31±13.58‡

67.72±19.22†§

62.64±11.99‡

0.001

 GCS score

8.89±4.17

9.60±4.07

9.23±3.78

0.276

 WBC count, 103/μL

12.8±14.0

11.6±10.4

11.6±6.6

0.507

 Hemoglobin level, g/dL

9.40±2.10

8.95±1.95

9.55±2.05

0.153

 Platelet count, 103/μL

158.3±114.4

132.2±88.9

166.5±78.6

0.111

 Na, mmol/L

139.7±7.89

138.6±6.33

139.2±6.33

0.387

 K, mmol/L

3.95±0.92

4.09±0.91

4.03±0.81

0.365

 C-reactive protein

13.15±10.67

14.27±11.52

12.90±9.20

0.657

 Albumin, mg/dl

2.83±0.79

2.92±0.45

2.94±0.55

0.209

 pH

7.43±0.09

7.44±0.08

7.42±0.08

0.553

 pCO2, mmHg

33.67±12.14

34.14±10.18

32.32±9.87

0.416

 HCO3, mmol/L

21.22±5.30

21.76±4.30

20.60±4.55

0.272

 PF ratio

270.7±149.1

243.1±134.9

271.9±136.2

0.399

  1. Significant difference (P<0.05) compared to the nonusers group
  2. Significant difference (P<0.05) compared to the nonselective BB group
  3. §Significant difference (P<0.05) compared to the β1-selective BB group
  4. BB β-blocker, APACHE Acute Physiology and Chronic Health Evaluation, DM diabetes mellitus, ESRD end stage renal disease, CAD coronary artery disease, COPD chronic obstruction pulmonary disease, UTI urinary tract infection, IAI intra-abdominal infection, GCS Glasgow Coma Scale, HR heart rate, BP blood pressure, WBC white blood cell, PF ratio PaO2/FiO2 ratio